$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-013/00
  • A61F-013/02
  • A61L-015/00
  • A61L-015/16
출원번호 US-0737828 (2000-12-14)
발명자 / 주소
  • Hsu, Tsung-Min
  • Luo, Eric C.
출원인 / 주소
  • Dermatrends, Inc.
대리인 / 주소
    Reed, Dianne E.Eberle, Shelley P.Reed & Eberle LLP
인용정보 피인용 횟수 : 11  인용 특허 : 36

초록

A method is provided for increasing the permeability of skin or mucosal tissue to transdermally administered oxybutynin. The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the drug through a body surface while minimizing the lik

대표청구항

A method is provided for increasing the permeability of skin or mucosal tissue to transdermally administered oxybutynin. The method involves use of a specified amount of a hydroxide-releasing agent, the amount optimized to increase the flux of the drug through a body surface while minimizing the lik

이 특허에 인용된 특허 (36)

  1. Mantelle Juan A. (Miami FL), Compositions and methods for topical administration of pharmaceutically active agents.
  2. Oloff Horst (Berlin DEX) Tack Johannes-Wilhelm (Berlin DEX) Windt Fred (Berlin DEX) Zimmermann Ingfried (Berlin DEX), Device for transdermal administration of active medicinal agents.
  3. Guittard George V. (Cupertino CA) Jao Francisco (San Jose CA) Marks Susan M. (San Jose CA) Kidney David J. (Sunnyvale CA) Gumucio Fernando (Santa Clara CA), Dosage form comprising oxybutynin.
  4. Therriault Donald J. (York PA) Rodgers Kenneth W. (York PA), Drug flux enhancer-tolerant pressure sensitive adhesive composition.
  5. Ron Eyal S. ; Bromberg Lev ; Temchenko Marina, End modified thermal responsive hydrogels.
  6. Cody Sharon L. ; Fegley Richard D. ; Hoy Michael R., Enhanced delivery of topical compositions containing flurbiprofen.
  7. Scholz Matthew T. ; Asmus Robert A. ; Hedenstrom John C., Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents.
  8. Ikeda Yasuo,JPX ; Okuyama Hirohisa,JPX ; Ishigaki Kenji,JPX ; Kasai Shuichi,JPX ; Imamori Katsumi,JPX, Hydrophilic adhesive masses.
  9. Yamanaka Akihito,JPX ; Kinoshita Takashi,JPX ; Sunami Masaki,JPX, Medicated plaster containing basic physiologically active agents and/or salts thereof.
  10. Foldvari Marianna,CAX, Method for preparing biphasic multilamellar lipid vesicles.
  11. Curtis Ernest S. ; Kalafsky Robert ; Kaplan Elinor R., Method of treating the skin with organic acids in anhydrous microsphere delivery systems.
  12. Parab Prakash ; Yu Cheng Der Tony ; Patel Bhiku, Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage.
  13. Aberg Gunnar (Westborough MA) McCullough John R. (Worcester MA), Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin.
  14. Lee Vincent H. (Monterey Park CA) Yen Wan-Ching (Columbus OH), Methods and compositions to enhance epithelial drug transport.
  15. Yamazaki Chika,JPX ; Sato Tadao,JPX ; Nagano Tatsuo,JPX, Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof.
  16. Ptchelintsev Dmitri ; Scancarella Neil ; Kalafsky Robert, Oxa acids and related compounds for treating skin conditions.
  17. Ptchelintsev Dmitri ; Scancarella Neil ; Kalafsky Robert, Oxa diacids and related compounds for treating skin conditions.
  18. Gale Robert M. (Los Altos CA) Lee Eun Soo (Redwood City CA) Taskovich Lina T. (Palo Alto CA) Burkoth Terry L. (Palo Alto CA), Oxybutynin transdermal device having decreased delamination.
  19. Wolter Karin (Melsbach DEX) Mller Walter (Neuwied DEX) Simon Gnter (Hillesheim DEX) Nalbach Christa (Leutesdorf DEX) Hoffmann Hans-Rainer (Neuwied DEX), Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a pr.
  20. Lerner E. Itzhak,ILX ; Rosenberger Vered,ILX ; Flashner Moshe,ILX, Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity.
  21. Venkateshwaran Srinivasan ; Fikstad David ; Ebert Charles D., Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents.
  22. Scarborough Robert M. ; Zhu Bing-Yan ; Su Ting, Selective factor Xa inhibitors.
  23. Miranda Jesus (Miami FL) Sablotsky Steven (Miami FL), Solubility parameter based drug delivery system and method for altering drug saturation concentration.
  24. Perricone Nicholas V., Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetra.
  25. Durif Franck (Durtol FRX) El-Rashidy Ragab (Deerfield IL), Transdermal administration of apomorphine.
  26. Durif Franck,FRX ; El-Rashidy Ragab, Transdermal administration of apomorphine.
  27. Lee Eun S. (Redwood City CA) Nedberge Diane E. (Los Altos CA) Yum Su I. (Los Altos CA), Transdermal administration of oxybutynin.
  28. Lhila Ramesh (South Windsor CT) Ganslaw Stuart (Simsbury CT) Serra Eleanor (West Springfield MA), Transdermal delivery of appetite suppressant drug.
  29. Lee Eun S. (Redwood City CA) Yum Su I. (Los Altos CA), Transdermal drug delivery device.
  30. Song Suk-Zu (Flanders NJ) Mehta Surendra C. (Randolph NJ) Rashidbaigi Zahra A. (Nutley NJ) Nesbitt Russell U. (Somerville NJ) Fawzi Mahdi B. (Flanders NJ), Transdermal matrix system.
  31. Therriault Donald J. ; Zajaczkowski Michael J. ; Stutzman Barbara A., Transdermal pressure sensitive adhesive drug delivery system.
  32. Gupte Arun R. (Ingelheim am Rhein DEX) Rohr Uwe (Gau Algesheim DEX) Zierenberg Bernd (Bingen DEX), Transdermal system for the administration of pharmacological compounds under pH-controlled conditions.
  33. Aberg A. K. Gunnar, Treating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutynin.
  34. Majeti Satyanarayana (Cincinnati OH), Treatment of nicotine craving and/or smoking withdrawal symptoms.
  35. Sawanishi Hiroyuki (Kanazawa JPX) Ito Yasuo (Katsuyama JPX) Kato Hideo (Fukui JPX) Koshinaka Eiichi (Katsuyama JPX) Ogawa Nobuo (Katsuyama JPX) Morikawa Kouji (Katsuyama JPX), Tricyclic compounds and method for treating allergic diseases.
  36. Hsu Tsung-Min ; Chen Tung Fen, Two-phase matrix for sustained release drug delivery device.

이 특허를 인용한 특허 (11)

  1. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  2. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  3. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  4. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  5. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
  6. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
  7. Bartels, Jennifer, Methods and compositions for oxygenation of skin to treat skin disorders.
  8. Zinger, Menni Menashe, Methods for the treatment of hyperhidrosis.
  9. Chase, Thomas N.; Clarence-Smith, Kathleen E., Oxybutynin-xanomeline transdermal therapeutic system combinations.
  10. Bartels, Jennifer, Permeable mixtures, methods and compositions for the skin.
  11. Ebert, Charles D.; Sanders, Steven W., Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로